Mass of intercostal muscles associates with risk of multiple exacerbations in COPD

Respiratory Medicine

Volumn 104, Issue 3, 2010, Pages 378-388

  Güerri, Roberto ^a   Gayete, Angel ^a   Balcells, Eva ^a   Ramirez Sarmiento, Alba ^a,c,d   Vollmer, Ivan ^b   Garcia Aymerich, Judith ^a   Gea, Joaquim ^a,c,d   Orozco Levi, Mauricio ^a,c,d  

^a HOSPITAL DEL MAR   (Spain)

^b Servei de Cardiologia   (Spain)

^c INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Atrophy; Exacerbation; Muscle mass; Respiratory muscles; Smoking

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; BODY MASS; BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HOSPITAL ADMISSION; HUMAN; INTERCOSTAL MUSCLE; MALE; MUSCLE MASS; MUSCLE STRENGTH; ONSET AGE; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 76649122545     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.10.015     Document Type: Article

References (48)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report (2001), National Heart, Lung, and Blood Institute, Bethesda, MD [NIH publication no. 2701]
2. Murray C.J.L., and Lopez A.D. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 349 (1997) 1269-1276
3. Okubadejo A.A., Jones P.W., and Wedzicha J.A. Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia. Thorax 51 (1996) 44-47
4. Peña V.S., Miravitlles M., Gabriel R., et al. Geographic variations in prevalence and underdiagnosis of COPD. Results of the IBERCOP multicentre epidemiological study. Chest 118 (2000) 981-989
5. Connolly M.J., Lowe D., Anstey K., et al. Admissions to hospital with exacerbations of chronic obstructive pulmonary disease: effect of age related factors and service organisation. Thorax 61 (2006) 843-848
6. Soler-Cataluna J.J., Martinez-Garcia M.A., Roman Sanchez P., et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 60 (2005) 925-931
7. Newman A.B., Haggerty C.L., Goodpaster B., et al. Strength and muscle quality in a cohort of well-functioning older adults: the health, aging and body composition study. J Am Geriatr Soc 51 (2003) 323-330
8. Metier E.J., Lynch N., Conwit R., et al. Muscle quality and age: cross-sectional and longitudinal comparisons. J Gerontol Biol Sci Med Sci 54A (1999) B207-B218
9. Baumgartner R.N. Body composition in healthy aging. Ann N Y Acad Sci 904 (2000) 437-448
10. Gallagher D., Visser M., De Meersman R.E., Sepúlveda D., Baumgartner R.N., Pierson R.N., Harris T., and Heymsfield S.B. Appendicular skeletal mass: effects of age, gender, and ethnicity. J Appl Physiol 83 (1997) 229-239
11. Evans W. Functional and metabolic consequences of sarcopenia. J Nutr 127 (1997) 9985-10035
12. Visser M., Deeg D.J., Lips P., et al. Skeletal muscle mass and muscle strength in relation to lower-extremity performance in older men and women. J Am Geriatr Soc 48 (2000) 381-386
13. Orozco-Levi M. Structure and function of respiratory muscles in patients with COPD: impairment or adaptation?. Eur Respir J 46 (2003) 41s-51s
14. Parker C.M., Voduc N., Aaron S.D., et al. Physiological changes during symptom recovery from moderate exacerbations of COPD. Eur Respir J 26 (2005) 420-428
15. Garcia-Aymerich J., Farrero E., Félez M.A., et al. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 58 (2003) 100-105
16. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Adopted by the 18th WMA General Assembly Helsinki, Finland, June 1964 and amended by the 52nd WMA General Assembly, Edinburgh, Scotland (October 2000). http://ohsr.od.nih.gov/guidelines/helsinki.html Accessible online at
17. Ramírez-Sarmiento A., Orozco-Levi M., Güell R., et al. Inspiratory muscle training in patients with chronic obstructive pulmonary disease: structural adaptation and physiologic outcomes. Am J Respir Crit Care Med 166 (2002) 1491-1497
18. Celli B.R., MacNee W., and and committee members. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23 (2004) 932-946
19. Siafakas N.M., Vermeire P., Pride N.B., et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 8 (1995) 1398-1420
20. Barbera J.A., Peces-Barba G., Agusti A.G.N., et al. Clinical guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease. Arch Bronconeumol 37 (2001) 297-316
21. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 152 (1995) S77-S121
22. Caskey C.I., Zerhouni E.A., Fishman E.K., et al. Aging of the diaphragm: a CT study. Radiology 171 (1989) 385-389
23. Larsson L., Grimby G., and Karlsson J. Muscle strength and speed of movement in relation to age and muscle morphology. J Appl Physiol Respir Environ Exercise Physiol 46 (1979) 451-456
24. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40 (1987) 373-383
25. Orozco-Levi M., Lloreta J., Minguella, et al. Injury of the human diaphragm associated with exertion and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164 (2001) 1734-1739
26. Kelley D.E., Slasky B.S., and Janosky J. Skeletal muscle density: effects of obesity and non-insulin-dependent diabetes mellitus. Am J Clin Nutr 54 (1991) 509-515
27. Schelesselman J. Case-control studies: design, conduct and analysis (1982), Oxford University Press, New York
28. Agusti A.G., Noguera A., Sauleda J., et al. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 21 (2003) 347-360
29. Landbo C., Prescott E., Lange P., et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160 (1999) 1856-1861
30. Gray-Donald K., Gibbons L., Shapiro S.H., et al. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 153 (1996) 961-966
31. Schols A.M., Slangen J., Volovics L., et al. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 (1998) 1791-1797
32. Prescott E., Almdal T., Mikkelsen K.L., et al. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J 20 (2002) 539-544
33. Celli B.R., Cote C.G., Marin J.M., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350 (2004) 1005-1012
34. Engelen M.P., Schols A.M., Baken W.C., et al. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in an outpatient population with chronic obstructive pulmonary disease. Eur Respir J 7 (1994) 1793-1797
35. Nishimura Y., Tsutsumi M., Nakata H., et al. Relationship between respiratory muscle strength and lean body mass in men with COPD. Chest 107 (1995) 1232-1236
36. Heymsfield S.B., and Williams P.J. Nutritional assessment by clinical and biochemical methods. In: Shils M.E., and Olson J.A. (Eds). Modern nutrition in health and disease (1994), Lea & Febiger, Philadelphia 812-841
37. Bernard S., Leblanc P., Whittom F., et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158 (1998) 629-634
38. Marquis K., Debigaré R., Lacasse Y., et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166 (2002) 809-813
39. Soler-Cataluna J.J., Sanchez-Sanchez L., Martinez-Garcia M.A., et al. Mid-arm muscle area is a better predictor of mortality than body mass index in COPD. Chest 128 (2005) 2108-2115
40. Coronell C., Orozco-Levi M., Méndez R., Ramírez-Sarmiento A., Gáldiz J.B., and Gea J. Relevance of assessing quadriceps endurance in patients with COPD. Eur Respir J 24 (2004) 129-136
41. Orozco-Levi M., Gea J., Lloreta J., et al. Subcellular adaptation of the human diaphragm in chronic obstructive pulmonary disease. Eur Respir J 13 (1999) 371-378
42. Vitacca M., Bianchi L., Barbano L., et al. Lung and respiratory muscle function at discharge from a respiratory intensive care unit. Monaldi Arch Chest Dis 63 (2005) 142-148
43. Wouters E.F.M. Chronic obstructive pulmonary disease 5: systemic effects of COPD. Thorax 57 (2002) 1067-1070
44. Congleton J. The pulmonary cachexia syndrome: aspects of energy balance. Proc Nutr Soc 58 (1999) 321-328
45. Schols A.M., Mostert R., Soeters P.B., et al. Body composition and exercise performance in patients with chronic obstructive pulmonary disease. Thorax 46 (1991) 695-699
46. Vermeeren M.A.P., Schols A.M.W.J., and Wouters E.F.M. Effects of an acute exacerbation on nutritional and metabolic profile of patients with COPD. Eur Respir J 10 (1997) 2264-2269
47. Anonymous. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 159 (1999) S1-S40
48. Orozco-Levi M., Lloreta J., and Gea J. The "oil-well analogy" as a comprehensive interpretation of factors leading to muscle injury and wasting. Ultrastruct Pathol 30 (2006) 247-252